HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymer genomics: shifting the gene and drug delivery paradigms.

Abstract
Pluronic, the A-B-A amphiphilic block copolymers of poly(ethylene oxide) and poly(propylene oxide), can up-regulate the expression of selected genes in cells and alter genetic responses to antineoplastic agents in cancer. Two key new findings are discussed in relation to current drug and gene delivery strategies. First, these block copolymers alone and in combination with a polycation, polyethyleneimine, can up-regulate the expression of reporter genes in stably transfected cells. This underscores the ability of selected synthetic polymers to enhance transgene expression through a mechanism that augments improved DNA delivery into a cell. Second, although, when used alone, Pluronic is "genetically benign," when combined with an antineoplastic agent, doxorubicin, it drastically alters pharmacogenomic responses to this agent and prevents the development of multidrug resistance in breast cancer cells. Collectively, these studies propose the need for a thorough assessment of pharmacogenomic effects of polymer therapeutics to maximize the clinical outcomes and understand the pharmacological and toxicological effects of polymer-based drugs and delivery systems.
AuthorsAlexander V Kabanov, Elena V Batrakova, Srikanth Sriadibhatla, Zhihui Yang, David L Kelly, Valery Yu Alakov
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 101 Issue 1-3 Pg. 259-71 (Jan 03 2005) ISSN: 0168-3659 [Print] Netherlands
PMID15588910 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Excipients
  • Polymers
Topics
  • Animals
  • Drug Delivery Systems
  • Drug Resistance, Multiple
  • Excipients
  • Gene Expression
  • Gene Transfer Techniques
  • Humans
  • Pharmacogenetics
  • Polymers (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: